• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Intersect ENT

edit

Intersect ENT Inc. (formerly Sinexus) is a medical device company pioneering novel therapies for Ear, Nose & Throat surgeons to utilize in providing improved treatment for their patients.

Recent Milestones

edit

• 
  Intersect ENT received $30M in Series D funding. (2/25/13)
  Posted 2/25/13 at 6:13pm via techcrunch.com
• 
  Intersect ENT received $30M in Venture Round funding. (11/1/10)
  Posted 11/1/10 at 7:18pm via finsmes.com
• 
  Intersect ENT added Casper de Clercq as Board of Director.
  Posted 2/25/13 at 9:52am

Videos

Screenshots

edit

Sources

1. Intersect ENT Closes $30M Round of Financing (finsmes.com) [edit]
2. Intersect ENT Lands $30M From Norwest, Kleiner, USVP & More For Its Innovative Sinus Drug & Device Combo (techcrunch.com) [edit]